BD - Earth day 2024

Baxter's Novum IQ Infusion Pump and Dose IQ Safety Software Cleared by FDA, Advancing Connected Infusion Therapy

Tuesday, April 02, 2024

Baxter International, known for its advancements in infusion therapies and technologies, has announced the FDA clearance of its Novum IQ large volume infusion pump (LVP) along with the Dose IQ Safety Software. This clearance signifies a significant step forward in Baxter's commitment to enhancing infusion therapy through innovation.

Heather Knight, Executive Vice President and Group President, Medical Products and Therapies at Baxter, emphasized the patient-centric approach of the Novum IQ platform, highlighting its role in improving care delivery. Knight stated, “Our primary goal is to provide our customers, clinicians, and patients with increased efficiency, safety, and informed decision-making opportunities. The Novum IQ platform marks a significant evolution in how connected and intelligent infusion therapy can revolutionize care delivery.”

The Novum IQ Infusion Platform integrates user experience across its LVP and SYR pumps, streamlining non-critical tasks and allowing clinicians to prioritize patient care. Key features include:

  • Novum IQ LVP and Novum IQ SYR infusion pumps with a shared user interface, simplifying the association between patients, medications, and pumps through digital barcode scanning.
  • Dose IQ Safety Software, featuring a customizable drug library and dose error reduction system, ensuring pumps are updated with the latest drug and dosage parameters specific to each facility. It includes titration error prevention technology for added safety.
  • IQ Enterprise Connectivity Suite, a scalable platform designed to streamline infusion system connectivity, enabling full bi-directional electronic medical record (EMR) interoperability, enhanced Continuous Quality Improvement (CQI) reports, and over-the-air software updates.

Baxter’s Novum IQ LVP facilitates the administration of high-volume infusions at faster rates, while Novum IQ SYR supports precise delivery of small amounts of fluid, often in pediatric or anesthesia care settings. Both Novum IQ LVP and SYR are now available for order in the U.S. Baxter plans to further expand the platform through ongoing product development and additional regulatory submissions.